Effect of ligand activation of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in human lung cancer cell lines

Toxicology

Volumn 254, Issue 1-2, 2008, Pages 112-117

  He, Pengfei ^a   Borland, Michael G ^a,b   Zhu, Bokai ^a   Sharma, Arun K ^c   Amin, Shantu ^c   El Bayoumy, Karam ^c   Gonzalez, Frank J ^d   Peters, Jeffrey M ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b Graduate Program in Biochemistry   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cell proliferation; Lung cancer; Nuclear receptor; Peroxisome proliferator activated receptor; PTEN

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE 4; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CAENORHABDITIS ELEGANS PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; LIGANDS; LUNG NEOPLASMS; NUCLEAR PROTEINS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PPAR DELTA; PPAR-BETA;

EID: 56049100021     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.09.023     Document Type: Article

References (18)

1. Burdick A.D., Bility M.T., Girroir E.E., Billin A.N., Willson T.M., Gonzalez F.J., and Peters J.M. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. Cell. Signal. 19 (2007) 1163-1171
2. Burdick A.D., Kim D.J., Peraza M.A., Gonzalez F.J., and Peters J.M. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. Cell. Signal. 18 (2006) 9-20
3. Di-Poi N., Tan N.S., Michalik L., Wahli W., and Desvergne B. Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol. Cell 10 (2002) 721-733
4. Fukumoto K., Yano Y., Virgona N., Hagiwara H., Sato H., Senba H., Suzuki K., Asano R., Yamada K., and Yano T. Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth. FEBS Lett. 579 (2005) 3829-3836
5. Girroir E.E., Hollingshead H.E., Billin A.N., Willson T.M., Robertson G.P., Sharma A.K., Amin S., Gonzalez F.J., and Peters J.M. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands inhibit growth of UACC903 and MCF7 human cancer cell lines. Toxicology 243 (2008) 236-243
6. Girroir E.E., Hollingshead H.E., He P., Zhu B., Perdew G.H., and Peters J.M. Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice. Biochem. Biophys. Res. Commun. 371 (2008) 456-461
7. Glick A.B., Perez-Lorenzo R., and Mohammed J. Context-dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis. Carcinogenesis 29 (2008) 9-14
8. Gupta R.A., Tan J., Krause W.F., Geraci M.W., Willson T.M., Dey S.K., and DuBois R.N. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13275-13280
9. Han S., Ritzenthaler J.D., Zheng Y., and Roman J. PPARbeta/delta agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-kappaB signals. Am. J. Physiol. Lung Cell Mol. Physiol. 294 (2008) L1238-L12249
10. Hollingshead H.E., Killins R.L., Borland M.G., Girroir E.E., Billin A.N., Willson T.M., Sharma A.K., Amin S., Gonzalez F.J., and Peters J.M. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines. Carcinogenesis 28 (2007) 2641-2649
11. Keith R.L., Miller Y.E., Hoshikawa Y., Moore M.D., Gesell T.L., Gao B., Malkinson A.M., Golpon H.A., Nemenoff R.A., and Geraci M.W. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res. 62 (2002) 734-740
12. Keith R.L., Miller Y.E., Hudish T.M., Girod C.E., Sotto-Santiago S., Franklin W.A., Nemenoff R.A., March T.H., Nana-Sinkam S.P., and Geraci M.W. Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice. Cancer Res. 64 (2004) 5897-5904
13. Kilgore K.S., and Billin A.N. PPARbeta/delta ligands as modulators of the inflammatory response. Curr. Opin. Investig. Drugs 9 (2008) 463-469
14. Kim D.J., Bility M.T., Billin A.N., Willson T.M., Gonzalez F.J., and Peters J.M. selectively induces differentiation and inhibits cell proliferation. Cell Death Differ. 13 (2006) 53-60
15. Lim H.J., Lee S., Park J.H., Lee K.S., Choi H.E., Chung K.S., Lee H.H., and Park H.Y. PPARdelta agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and migration via inhibition of cell cycle. Atherosclerosis (2008) 10.1016/j.atherosclerosis.2008.05.023
16. Muller-Brusselbach S., Ebrahimsade S., Jakel J., Eckhardt J., Rapp U.R., Peters J.M., Moll R., and Muller R. Growth of transgenic RAF-induced lung adenomas is increased in mice with a disrupted PPARbeta/delta gene. Int. J. Oncol. 31 (2007) 607-611
17. Pedchenko T.V., Gonzalez A.L., Wang D., Dubois R.N., and Massion P.P. Peroxisome proliferator-activated receptor {beta}/{delta} expression and activation in lung cancer. Am. J. Respir. Cell Mol. Biol. 39 (2008) 689-696
18. Peters J.M., Hollingshead H.E., and Gonzalez F.J. Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease. Clin. Sci. (Lond.) 115 (2008) 107-127